300+ investors in your industry, stage, and region Get
Any industry
Artificial Intelligence
Google
EdTech
Clean Energy
Retail
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Organic Food
Email
Fitness
CleanTech
Energy
Health Care
Machine Learning
Agriculture (AgTech)
Marketplace
Gaming
Facebook
Blockchain
B2B
Social Network
Big Data
Video Games
Education
Wellness
Medical Device
Mobile
Construction
Automotive
Legal
Sports
eSports
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Theatre
Recruiting
Crowdfunding
Web3
Medical
Fashion
Social
Venture Capital
Infrastructure
Beauty
Celebrity
Cannabis
Climate
LGBT
Publishing
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Music
Real Estate
Art
Sporting Goods
Digital Media
Finance
Manufacturing
FinTech
Social Media
Financial Services
Franchise
Non Profit
Mobile Advertising
Internet
Android
Biotech
Proptech
Sustainability
Hardware
Transportation
Impact
Enterprise
Community
Media (Entertainment)
Any country
Burkina Faso
South Korea
Africa
LATAM
Singapore
Brazil
Saudi Arabia
Oceania
Greece
Gibraltar
Norway
Liberia
Mexico
Taiwan
Sweden
Zambia
Puerto Rico
Tunisia
Russian Federation
Togo
Tajikistan
Zimbabwe
Nigeria
Guinea
Nepal
Iran
Kyrgyzstan
Isle of Man
Pakistan
Romania
Cameroon
Oman
Colombia
New Zealand
Australia
China
Sri Lanka
Armenia
Costa Rica
Switzerland
Czech Republic
Cayman Islands
Kenya
Kuwait
Kazakhstan
Jamaica
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uganda
Turkey
Uzbekistan
Venezuela
Guatemala
Moldova
Malawi
Seychelles
Botswana
Japan
United Kingdom
Canada
Ireland
South Africa
Egypt
France
Georgia
Denmark
Croatia
Hong Kong
Ghana
Iraq
Mali
Morocco
Myanmar
Latvia
Malaysia
Poland
Philippines
Portugal
Sierra Leone
Rwanda
El Salvador
Senegal
Thailand
Uruguay
Tanzania
India
Germany
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Cyprus
Qatar
United Arab Emirates
Spain
Europe
Angola
Argentina
Bangladesh
Barbados
Belgium
Ethiopia
Jordan
Austria
Azerbaijan
Ecuador
Bulgaria
Bahrain
Bahamas
Faroe Islands
Jersey
Estonia
Bolivia
Algeria
Belize
Belarus
Finland
Italy
Hungary
Israel
Grenada
Honduras
Iceland
Cambodia
Lithuania
Liechtenstein
Lebanon
Mongolia
Slovenia
Peru
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Life Science VC Funds & Investors in Asia (July 2026)

The most active venture capital funds investing in Asia Life Science startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Asia Life Science startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Prox Ventures
VC Fund
9 China, United States, United Kingdom Seed, Series A Medical, Biotechnology, Health Care $1.9M–$28M
Qiming Venture Partners
VC Fund
6 China, United States, Hong Kong Series B, Series A, Series C Health Care, Biotechnology, Medical $5M–$134M
Mitsubishi UFJ Capital
VC Fund
6 Japan, United States, Singapore Series A, Series B Information Technology, Software, Health Care $1.2M–$269M
Hillhouse Investment
VC Fund
6 China, United States, Singapore Series B, Series A, Series C Biotechnology, Health Care, Software $2.9M–$220M
Linear Capital
VC Fund
5 China, Singapore, Switzerland Seed, Angel, Series A Artificial Intelligence, Software, Manufacturing $1.4M–$122M
HSG
VC Fund
5 China, United States, Hong Kong Series A, Series B, Series C Health Care, Biotechnology, Software $4.4M–$214M
SMBC Venture Capital
VC Fund
5 Japan, United States, Singapore Series A, Series B Information Technology, Software, Health Care $2.3M–$269M
EFung Capital
VC Fund
4 China, United States, India Series B, Series A, Series C Health Care, Biotechnology, Medical $1.4M–$87M
Osaka University Venture Capital
VC Fund
4 Japan Seed, Series A Biotechnology, Health Care, Manufacturing $3M–$142M
Lenovo Capital and Incubator Group (LCIG)
VC Fund
4 China, Hong Kong, United States Series A, Seed, Series B Manufacturing, Artificial Intelligence, Software $1.5M–$150M
SBI Investment
VC Fund
4 Japan, South Korea, United States Series B, Series A Software, Information Technology, Financial Services $2M–$227M
Miyako Capital
VC Fund
4 Japan, United States, United Kingdom Series A, Seed, Series B Medical, Biotechnology, Information Technology $750k–$354M
Nissay Capital
VC Fund
4 Japan, United States, Ethiopia Seed, Series A Health Care, Information Technology, Medical $610k–$71M
Huagai Capital
VC Fund
4 China, United States, Germany Series A, Series B, Angel Health Care, Biotechnology, Medical $425k–$90M
Baidu Ventures
VC Fund
4 China, United States, Singapore Series A, Seed, Series B Artificial Intelligence, Health Care, Biotechnology $1.4M–$145M
UntroD Capital
VC Fund
4 Japan, Singapore, Austria Seed, Series A Manufacturing, Biotechnology, Health Care $772k–$241M
DG Daiwa Ventures
VC Fund
4 Japan, United States, India Seed, Series A, Series B Software, FinTech, Internet $679k–$122M
Hillhouse Ventures
VC Fund
4 China, Singapore, Norway Series A, Series B, Seed Manufacturing, Biotechnology, Health Care $10M–$120M
Vinno Capital
VC Fund
4 China, United States Series A, Series B, Seed Manufacturing, Semiconductor, Medical $1.4M–$142M
Mizuho Capital
VC Fund
3 Japan, United States, Singapore Series A, Series B Information Technology, Software, Internet $1.8M–$340M
CITIC Capital Holdings
VC Fund
3 China, United States, Japan Series A, Series B, Series C Manufacturing, Health Care, E-Commerce $2.8M–$230M
Tianjin Venture Capital
VC Fund
3 China, United States Seed, Series A Manufacturing, Information Technology, Biotechnology $202k–$31M
Nippon Venture Capital
VC Fund
3 Japan, United States, Indonesia Series A, Series B Software, Health Care, Information Technology $1.5M–$269M
ZSVC
VC Fund
3 China, United States, India Series A, Seed, Series B Manufacturing, Medical, Health Care $1.4M–$85M
JAFCO
VC Fund
3 Japan, United States, Israel Series A, Series B Information Technology, Software, Artificial Intelligence $1.9M–$198M
CD Capital
VC Fund
3 China, United States Series A, Series B, Seed Health Care, Biotechnology, Medical Device $1.4M–$34M
Legend Capital
VC Fund
3 China, United States, South Korea Series B, Series A, Series C Health Care, Medical, Biotechnology $2.9M–$156M
Senshu Ikeda Capital
VC Fund
3 Japan Series A, Seed Software, Manufacturing, Internet $1M–$92M
BioVenture
VC Fund
3 China, United States, Hong Kong Series A, Series B, Seed Health Care, Medical, Biotechnology $3M–$73M
Dalton Venture
VC Fund
3 China, India, Canada Seed, Series A, Series B Health Care, Medical, Biotechnology $450k–$47M
ULTIMA
VC Fund
3 China Angel, Series A Hardware, Software, Agriculture $1.6M–$15M
Northern Light Venture Capital
VC Fund
3 China, United States, South Korea Series A, Series B, Seed Health Care, Medical, Biotechnology $1.3M–$100M
Japan Science and Technology Agency
VC Fund
3 Japan Series A, Seed Medical, Biotechnology, Manufacturing $1.7M–$255M
Entrepreneurship Relay Group
VC Fund
3 China Series A, Angel Manufacturing, Software, Enterprise $222k–$27M
MiraclePlus
VC Fund
3 China, United States, Singapore Seed, Angel, Pre-Seed Artificial Intelligence, Software, Information Technology
Anzu Partners
VC Fund
3 United States, Canada, Spain Series A, Series B Biotechnology, Software, Manufacturing
Angel Bridge
VC Fund
3 Japan Series A, Seed, Series B Information Technology, Software, Consulting $792k–$62M
Keio Innovation Initiative
VC Fund
3 Japan, United Kingdom Series A, Seed Health Care, Medical, Biotechnology $1.5M–$64M
ASBV
VC Fund
3 China, Australia, Hong Kong Seed, Series A, Angel Health Care, Medical, Biotechnology $425k–$31M
WuXi AppTec
VC Fund
3 United States, China, Israel Series A, Series B, Series C Biotechnology, Pharmaceutical, Health Care $6M–$130M
Zoo Capital
VC Fund
2 China, Hong Kong, United States Seed, Series A, Series B Artificial Intelligence, Software, Biotechnology
CentreGold Capital
VC Fund
2 United States, China, Canada Seed, Series A, Angel Medical Device, Internet, Health Care
Gaw Capital Partners
VC Fund
2 China, Singapore, United States Series A, Series C, Seed Real Estate, Property Management, Hospitality
Haitang Fund
VC Fund
2 China Seed, Series A Manufacturing, Biotechnology, Medical
Matrix Partners China
VC Fund
2 China, United States, Singapore Series A, Series B, Seed Health Care, Biotechnology, Software $1.4M–$113M
Med-Fine Capital
VC Fund
2 China, Hong Kong, United States Series A, Seed, Series B Medical, Health Care, Biotechnology $2.8M–$60M
Lilly Asia Ventures
VC Fund
2 China, United States, Hong Kong Series A, Series B, Series C Biotechnology, Health Care, Medical $14M–$259M
Loyal Valley Capital
VC Fund
2 China, United States, Hong Kong Series C, Series A, Series B Biotechnology, Health Care, Pharmaceutical $2.7M–$300M
UTEC - The University of Tokyo Edge Capital Partners
VC Fund
2 Japan, United States, India Seed, Series A Health Care, Biotechnology, Medical $3.1M–$85M
Huimei Capital
VC Fund
2 China, United States, Japan Series A, Series B, Series C Biotechnology, Health Care, Medical $10M–$227M
Access all 50 VC funds in Asia Life Science startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Prox Ventures
VC Fund · Shanghai, Shanghai, China · 9 investments in Asia Life Science startups, 7 in the past 12 months

Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential.They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many yearsof remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health.

Show more...

Investment focus

  • Industry: Medical, Biotechnology, Health Care
  • Stage:Seed, Series A
  • Geography: China, United States, United Kingdom

Investor stats

  • Total investments: 79
  • Round size: Seed $1.9M–$5.6M; Series A $2.8M–$28M
  • Lead/follow: 19% lead, 81% follow

Portfolio highlights

  • Shengxin Medical — Shengxin Medical is a cardiovascular interventional medical device developer, dedicated to creating innovative, high-quality solutions that improve the diagnosis, treatment, and management of cardiovascular diseases, while advancing minimally invasive medical technologies to enhance patient outcomes and clinical efficiency.
  • Bluesail Surgical — Bluesail Surgical is a surgical device company that specializes in the development of innovative surgical instruments for cardiovascular and cerebrovascular treatments.
  • Kingsung Medical Group
Show all investments...

Qiming Venture Partners
VC Fund · Shanghai, Shanghai, China · 6 investments in Asia Life Science startups

Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong in China, and Singapore.Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companiesin the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages.Since our debut, we have backed over 530 fast-growing and innovative companies. Over 200 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 70 portfolio companies that have achieved unicorn or super unicorn status.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series B, Series A, Series C
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 803
  • Round size: Series A $5M–$68M; Series B $9.4M–$100M; Series C $14M–$134M
  • Lead/follow: 43% lead, 57% follow
  • Last fund: Likely still investing — raised $887M in 2023

Portfolio highlights

  • Chuman — Chuman is a UGC Pan-Secondary Creation Community, providing creative platforms and studios for comic creators, and providing IP incubation and resource docking services. Users can quickly generate a lot of content through third-party or official materials, and can make friends, transactions and other activities within the community through thecreation, while the APP also supports the dialogue novel reading function.
  • Wholee — Wholee is a member-only zero-markup store.
  • Zeen Health — Zeen Health is a digital therapeutics company that provides mental health services. Zeen Health was founded in 2019 and was headquartered in Shenzhen, China.
Show all investments...

Mitsubishi UFJ Capital
VC Fund · Tokyo, Tokyo, Japan · 6 investments in Asia Life Science startups

Mitsubishi UFJ Capital is a venture capital firm focusing on life science, ICT, and high technology investments.

Show more...

Investment focus

  • Industry: Information Technology, Software, Health Care
  • Stage:Series A, Series B
  • Geography: Japan, United States, Singapore

Investor stats

  • Total investments: 547
  • Round size: Series A $1.2M–$86M; Series B $4.2M–$269M
  • Lead/follow: 5% lead, 95% follow
  • Last fund: May invest from a new fund soon — raised $1.4B in 2020

Portfolio highlights

  • Caguuu — Caguuu offers high-quality designer furniture at affordable prices, through e-commerce, eliminating middlemen and store operating costs.
  • Diggle — DIGGLE is a service that provides fundamental management accounting management on the cloud called fraud management. It is possible to reduce the mistakes and man-hours of the fraud management task and easily carry out the fraud management task even if it is not an expert in finance or accounting.DIGGLE covers budget creation work and budgetrecord comparison work, especially in the foreman management work. In the budget creation work, the KPI and the budget are automatically created by inputting the target numerical value to the preset parameters utilizing the budget generator function, while the forecast contrasting work is made up of the financial information, non-financial information It is easy to calculate by simply entering the numerical value, and it is possible to carry out calculation of the forecast contrast.
  • Instalimb — Instalimb is the world's first 3D printing prosthesis business.
Show all investments...

Hillhouse Investment
VC Fund · Changyang, Beijing, China · 6 investments in Asia Life Science startups

Founded in 2005, Hillhouse is a leading global investment management firm, active across public equity, private equity, real estate and private credit. The firm invests over a long-term horizon and partners with exceptional entrepreneurs to deliver sustainable value creation for quality companies.Hillhouse is a full life-cycle private equityfirm, investing for the long term across opportunities in the healthcare, business services, consumer, and industrials sectors. The firm manages capital on behalf of global institutions such as non-profit foundations, endowments, and pensions.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Series B, Series A, Series C
  • Geography: China, United States, Singapore

Investor stats

  • Total investments: 331
  • Round size: Series A $2.9M–$142M; Series B $14M–$219M; Series C $15M–$220M
  • Lead/follow: 38% lead, 62% follow
  • Last fund: May invest from a new fund soon — raised $11B in 2018

Portfolio highlights

  • Sainte — Sainte is a company which provides professional nutritional solutions for babies with different nutritional needs
  • Vita Dynamics — Vita Dynamics involves learning through real-world interactions by developing robots that can physically engage with their environment, they can adapt more naturally and efficiently.
  • NeueHCT — Horizon Continental Technology is a joint venture between Continental Group and Horizon Robotics
Show all investments...

Linear Capital
VC Fund · Shanghai, Shanghai, China · 5 investments in Asia Life Science startups

Linear Capital is a Frontier Tech Fund founded in 2014 by Harry Wang, Facebook's first Chinese R&D manager. We currently manage 10 funds with AUM of more than $2 billion.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Manufacturing
  • Stage:Seed, Angel, Series A
  • Geography: China, Singapore, Switzerland

Investor stats

  • Total investments: 88
  • Round size: Seed $1.4M–$122M; Angel $1.4M–$122M; Series A $5.7M–$50M
  • Lead/follow: 32% lead, 68% follow
  • Last fund: Likely still investing — raised $500M in 2021

Portfolio highlights

  • Pacdora — Pacdora is an incredibly user-friendly online mockup design platform that boasts an extensive collection of 3D mockups and box templates. Whether you're a seasoned designer or just starting out, you can effortlessly create eye-catching mockups in no time. Plus, with our powerful 3D modeling software and a suite of AI design assistant tools atyour fingertips, your creative possibilities are limitless. Unleash your imagination with Pacdora today!
  • Rino — L4 autonomous delivery vehicles by Rino.ai serve logistics, retail, and cold chain needs across 100+ cities. Revolutionize your logistics with Autonomous Delivery Vehicles, offering a safe, efficient, and eco-friendly solution for last-mile delivery in urban and rural settings.
  • ACXEL Tech — ACXEL Tech develops large area electronics have given us flat panel displays and flexible, wearable devices. ACXEL takes these ‘active’ pixels and puts them to work transporting liquid droplets – precisely and at amazing speed.Millions of pixels are transformed into tiny engines moving samples around via a high throughput, low cost andprogrammable platform, offering a wide range of possibilities in chemistry, biology and medtech.
Show all investments...

HSG
VC Fund · Beijing, Beijing, China · 5 investments in Asia Life Science startups, 10 in the past 12 months

We help founders build enduring companies.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Software
  • Stage:Series A, Series B, Series C
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 751
  • Round size: Series A $4.4M–$100M; Series B $12M–$200M; Series C $26M–$214M
  • Lead/follow: 42% lead, 58% follow
  • Last fund: Likely still investing — fund raised in 2024

Portfolio highlights

  • MarqVision — Effortlessly discover and remove counterfeits to protect your sales and reputation.
  • Midas — Midas is the first neobroker of Turkey, providing zero commission Turkish and American stocks.
  • Yunzhou Zhiwei — Yunzhou Zhiwei is a high-tech startup focused on serving large-scale equipment maintenance industries such as aviation, aerospace, shipbuilding, and rail transit. It leverages smart maintenance concepts and advanced digital technologies to make complex equipment maintenance more efficient and lean. The company drives industrial transformationtoward intelligent maintenance, helping enterprises enhance growth, efficiency, and operational excellence.
Show all investments...

SMBC Venture Capital
VC Fund · Tokyo, Tokyo, Japan · 5 investments in Asia Life Science startups

Sumitomo Mitsui Banking Corporation (SMBC) and its group companies offer a broad range of financial services centered on banking. They are also engaged in the leasing, securities, credit card, investment, mortgage securitization, venture capital and other credit related businesses. The following lists the activities of SMBC, its subsidiaries andaffiliates in the various business segments.

Show more...

Investment focus

  • Industry: Information Technology, Software, Health Care
  • Stage:Series A, Series B
  • Geography: Japan, United States, Singapore

Investor stats

  • Total investments: 551
  • Round size: Series A $2.3M–$128M; Series B $3.2M–$269M
  • Lead/follow: 4% lead, 96% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Etaily — Etaily provides e-commerce and retail solutions in the Philippines, enabling brands with end-to-end services, from store management to fulfillment.
  • Fermelanta — Fermelanta produces rare plant-based ingredients through microbial fermentation. It engineers a cell to build a biosynthetic pathway of target molecules with gene transfer and disruption.
  • Neusignal Therapeutics — Neusignal Therapeutics is a medical company that develops therapeutic medicines for dementia and psychiatric illnesses.
Show all investments...

EFung Capital
VC Fund · Shenzhen, Guangdong, China · 4 investments in Asia Life Science startups

Shenzhen EFUNG Investment Management Enterprise L. P. is one of China's earliest institutions investing in professional biomedical industries. Their strong research team and great investment returns made us won 'The Most Pioneering VC Institution” 'The Most Dynamic Pharmaceutical VC Institution in China' and 'The Top Ten VCInstitutions in Shenzhen'. With this influence, EFUNG has drawn a lot of attention from the medical and life science industry. And it is interviewed by Nature, which is the most authoritative science magazine in the world. Over a decade of years, they have been focusing on the medical and health industry, especially the VC and PE investment business of novel drugs and high-end medical devices. The mission of EFUNG is to drive the industrialization of medical researches by capital and to gain rich returns to investors. EFUNG has deeply screened and invested in more than 20 domestic and international premium enterprises, such as Chipscreen Biosciences, Frontier Biotechnologies, Ascentage Pharma, Lifotronic, Aridis Pharmaceuticals, and Centrexion.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series B, Series A, Series C
  • Geography: China, United States, India

Investor stats

  • Total investments: 74
  • Round size: Series A $1.4M–$76M; Series B $14M–$87M; Series C $14M–$74M
  • Lead/follow: 35% lead, 65% follow

Portfolio highlights

  • Carbonology — Carbonology is a carbon capture company that produces fuels, chemicals, and polyesters.
  • Barty Medical — Barty Medical develops, manufactures, and markets coronary drug balloons, peripheral drug balloons, coronary PTCA balloons, peripheral PTA balloons, peripheral drug stents, supporting catheter sheaths, vascular interventional devices, and implanted devices.
  • Yuewei Medical — Yuewei Medical is a developer of cardiac surgery interventional medical devices.
Show all investments...

Osaka University Venture Capital
VC Fund · Osaka, Osaka, Japan · 4 investments in Asia Life Science startups

Osaka University Venture Capital is a venture capital firm that focuses on early-stage ventures in the fields of life innovation, green innovation, and platform technology. The firm was founded in 2014 and based in Osaka, Japan.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Manufacturing
  • Stage:Seed, Series A
  • Geography: Japan

Investor stats

  • Total investments: 82
  • Round size: Seed $4.5M–$50M; Series A $3M–$142M
  • Lead/follow: 34% lead, 66% follow

Portfolio highlights

  • LQUOM — QWAVE offers cryptography communication technology.
  • Orbital Lasers — Orbital is a space tech company that provides space debris business to remove debris and a satellite LiDAR business to provide surface data.
  • Toregem BioPharma — Toregem BioPharma is a startup from Kyoto University that develops a treatment for congenital adentia. Toregem BioPharma is headquartered in Kyoto, Japan.
Show all investments...

Lenovo Capital and Incubator Group (LCIG)
VC Fund · Beijing, Beijing, China · 4 investments in Asia Life Science startups

Lenovo Capital and Incubator Group is an accelerator and venture capital firm.

Show more...

Investment focus

  • Industry: Manufacturing, Artificial Intelligence, Software
  • Stage:Series A, Seed, Series B
  • Geography: China, Hong Kong, United States

Investor stats

  • Total investments: 265
  • Round size: Seed $1.5M–$42M; Series A $2.8M–$73M; Series B $5.5M–$150M
  • Lead/follow: 25% lead, 75% follow
  • Last fund: May invest from a new fund soon — raised $500M in 2016

Portfolio highlights

  • Deepin Technology — Deepin Technology is a company that utilizes artificial intelligence, quantum chemistry, and high-throughput experiment technologies to enhance the efficiency and workflow of chemical material innovation. it offers efficient R&D solutions for chemical materials, aiming to solve lab bottlenecks, promote innovative research, and enhance customervalue.
  • SenseTime Medical — SenseTime Medical promotes the development and implementation of its medical big model and provides smart health solutions.
  • Shenzhen Urban Transport planning Center — Shenzhen Urban Transport planning Center provides traffic information engineering and technical services in China.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
SBI Investment
VC Fund · Minato, Chiba, Japan · 4 investments in Asia Life Science startups

SBI Investment supports the business development and growth of private venture companies through fund investment. It manages and manages venture capital funds under the management philosophy of becoming a leading company responsible for the creation and development of core industries in the 21st century as a "new industry creator".SBIInvestment has invested in a total of 986 companies in the past, of which 169 (17.1% of investment companies) have exited through IPO or M & A.

Show more...

Investment focus

  • Industry: Software, Information Technology, Financial Services
  • Stage:Series B, Series A
  • Geography: Japan, South Korea, United States

Investor stats

  • Total investments: 374
  • Round size: Series A $2M–$156M; Series B $4.9M–$227M
  • Lead/follow: 25% lead, 75% follow
  • Last fund: May invest from a new fund soon — raised $1.1B in 2020

Portfolio highlights

  • Alxtal — Alxtal is a tech company who optimize the development, design, and manufacturing processes of the manufacturing industry with IT and AI.
  • Direava
  • Zerodoor HD — Zerodoor HD specializes in digital transformation in constructing industry.
Show all investments...

Miyako Capital
VC Fund · Kyoto, Kyoto, Japan · 4 investments in Asia Life Science startups

Miyako Capital is the venture capital that manages Kyoto University 2nd Venture Fund (KUVF). The company was founded in 2013 and based in Kyoto & Tokyo, Japan. Investment fields are: 1) Life Science, Biotechnology: Drug creation, regenerative medicine, medical beauty equipment, medical services.2) Agri-Food: Industrialization,agricultural and fishery products growth-promoting technology, specified health food, health food.3) Environment, Energy: Alternative energy, and related technologies.4) IT, Electronics: Web, mobile related devices and application, telecommunication technology, security, consumer and business oriented application, mechatronic, robot.5) New services utilizing state-of-art technology.Investment stages: Primary investment stages are initial-growth stages of seed and early. However, we aim at all growth stages and make investment in post-IPO portfolio companies as well as public companies that are related with Kyoto University.

Show more...

Investment focus

  • Industry: Medical, Biotechnology, Information Technology
  • Stage:Series A, Seed, Series B
  • Geography: Japan, United States, United Kingdom

Investor stats

  • Total investments: 52
  • Round size: Seed $750k–$43M; Series A $6.1M–$75M; Series B $3.7M–$354M
  • Lead/follow: 19% lead, 81% follow
  • Last fund: May invest from a new fund soon — raised $1.4B in 2019

Portfolio highlights

  • Mui Lab — Mui is an aesthetically-pleasing wooden IoT device connected to a cloud service. By accessing information through natural wood, we can rethink a new type of lifestyle.
  • Flosfia — FLOSFIA is a spin-off from a research of Kyoto University, specializing in film-formation by mist chemical vapor deposition (CVD). Making use of physical properties of gallium oxide (Ga2O3), FLOSFIA has devoted to development of low-loss power devices.
  • Fermelanta — Fermelanta produces rare plant-based ingredients through microbial fermentation. It engineers a cell to build a biosynthetic pathway of target molecules with gene transfer and disruption.
Show all investments...

Nissay Capital
VC Fund · Tokyo, Tokyo, Japan · 4 investments in Asia Life Science startups

Nissay Capital is a venture capital Company specializing in seed, start-up, growth capital, middle stage, and later stage investment.

Show more...

Investment focus

  • Industry: Health Care, Information Technology, Medical
  • Stage:Seed, Series A
  • Geography: Japan, United States, Ethiopia

Investor stats

  • Total investments: 254
  • Round size: Seed $610k–$43M; Series A $2.5M–$71M
  • Lead/follow: 25% lead, 75% follow

Portfolio highlights

  • Welyco — Welyco is an information technology company.We operate smart restaurant "solto". Utilize IT to realize efficient and diverse restaurant management.
  • Reborna Biosciences — Reborna Biosciences provides research and development in the field of genetic diseases. The company develops therapeutic options for area of unmet medical needs in genetic rare disease. The company's technology enables low-molecular compounds to target ribonucleic acid. The company provides new disease-modifying drugs for patients sufferingfrom rare genetic diseases including spinal muscular atrophy.
  • Fabric Tokyo — FABRIC TOKYO is a Japanese startup provides a direct-to-consumer custom-made apparel brand. (former-company name Lifestyle Design Co., Ltd.). It enables customers to save their sizes, idea fabrics, and favorite designs, allowing them to make their original clothing later.FABRIC TOKYO was founded in 2012 by Yuichiro Mori and is based in Tokyo,Japan.
Show all investments...

Huagai Capital
VC Fund · Beijing, Beijing, China · 4 investments in Asia Life Science startups, 8 in the past 12 months

Huagai Capital is a private equity investment firm that invests in start-up or growth companies in the areas of healthcare, TMT, and culture.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A, Series B, Angel
  • Geography: China, United States, Germany

Investor stats

  • Total investments: 135
  • Round size: Angel $425k–$15M; Series A $1.4M–$63M; Series B $3.5M–$90M
  • Lead/follow: 42% lead, 58% follow
  • Last fund: May invest from a new fund soon — raised $430M in 2018

Portfolio highlights

  • PrinoPharma — PrinoPharma focuses on developing novel druggable sites targeting difficult-to-drug or existing druggable targets.
  • SenseTime — SenseTime Medical is an AI healthcare firm that creates solutions for hospitals, research institutions, and the global medical market. Through its SenseCare platform, the company provides over 40 specialized AI modules and maintains strategic partnerships with organizations like Roche, Midea, and Ruijin Hospital to streamline patient services andmedical innovation.
  • Falcon Technology — Falcon Technology focuses on DSA processor design innovation, developing a dedicated computing technology ecosystem based on the RISC-V architecture to deliver high-performance, energy-efficient processing solutions for next-generation intelligent computing applications.
Show all investments...

Baidu Ventures
VC Fund · Beijing, Beijing, China · 4 investments in Asia Life Science startups

Doma Protocol is a purpose-built blockchain to modernize and unlock the liquidity of over 362M existing and future domains

Show more...

Investment focus

  • Industry: Artificial Intelligence, Health Care, Biotechnology
  • Stage:Series A, Seed, Series B
  • Geography: China, United States, Singapore

Investor stats

  • Total investments: 216
  • Round size: Seed $1.9M–$14M; Series A $1.4M–$43M; Series B $8M–$145M
  • Lead/follow: 23% lead, 77% follow

Portfolio highlights

  • Sondit — Sondit specializes in R&D and manufacturing of civilian radar systems. It includes intelligent transportation, intelligent security, vehicle-road coordination, and other fields. It engaged in traffic information monitoring and urban traffic management in the field of the intelligent transportation industry.
  • Fastlane — We take innovative brands global. Fastlane is a full-service D2C solutions provider that assists enterprises with brand development, business infrastructure, and sales creation/growth in European, North American and Asian markets. We offer a superior one-stop solution, with expertise in go-to-market strategy, traditional and digital marketing,PR, logistics, e-commerce, sales, and platform development. We work with companies big and small, and our custom-tailored solutions range in scope from basic consulting services to 360° turnkey operations.
  • Automation Hero — Reduce your company's document processing time with an intelligent automation platform that's simple, secure, and accurate.
Show all investments...

UntroD Capital
VC Fund · Sumida, Tokyo, Japan · 4 investments in Asia Life Science startups

UntroD Capital is an R&D-based innovative technology that specializes in social implementation.

Show more...

Investment focus

  • Industry: Manufacturing, Biotechnology, Health Care
  • Stage:Seed, Series A
  • Geography: Japan, Singapore, Austria

Investor stats

  • Total investments: 130
  • Round size: Seed $772k–$43M; Series A $2.1M–$241M
  • Lead/follow: 40% lead, 60% follow
  • Last fund: Likely still investing — fund raised in 2024

Portfolio highlights

  • CastBio — Castbio specializes in antibody-drug conjugate-based drug discovery research and development. Along with medications, it also creates research reagents, medical equipment, in vitro diagnostic items, and offers drug discovery consulting.
  • 3DC — 3DC develops and manufactures a new carbon material, graphene meso sponge (GMS), for electrodes in next-generation batteries, capacitors, fuel cells and other energy storage and generation devices.
  • Formas.AI — Formas.AI is a multi-modal, AI-powered design platform specifically built for architects, designers, and educators to generate and visualize creative architectural concepts.
Show all investments...

DG Daiwa Ventures
VC Fund · Marunouchi, Tokyo, Japan · 4 investments in Asia Life Science startups, 13 in the past 12 months

DG Daiwa Ventures invests in start-up companies with next-generation technology and provides business development support. It is focused on blockchain, xR, AI, security, and BioHealth, as they are likely to be at the foundations of future businesses. In addition to the five core technologies, the fund will also focus on IoT technologies, whichoften overlap or serve as an application layer.

Show more...

Investment focus

  • Industry: Software, FinTech, Internet
  • Stage:Seed, Series A, Series B
  • Geography: Japan, United States, India

Investor stats

  • Total investments: 81
  • Round size: Seed $679k–$8M; Series A $1.1M–$103M; Series B $6.5M–$122M
  • Lead/follow: 16% lead, 84% follow

Portfolio highlights

  • Imiron — Imiron the process and tools used for modeling mathematical behavior in order to comprehend its fundamentals.
  • Dioseve — Dioseve is providing novel possibilities for all life.
  • CULTA
Show all investments...

Hillhouse Ventures
VC Fund · Singapore, Central Region, Singapore · 4 investments in Asia Life Science startups

Hillhouse Venture Capital is an investment institution established by Hillhouse Capital that focuses on investing in early-stage startups.

Show more...

Investment focus

  • Industry: Manufacturing, Biotechnology, Health Care
  • Stage:Series A, Series B, Seed
  • Geography: China, Singapore, Norway

Investor stats

  • Total investments: 74
  • Round size: Seed $10M–$120M; Series A $10M–$85M; Series B $14M–$99M
  • Lead/follow: 45% lead, 55% follow

Portfolio highlights

  • Yatsen Holding — Yasten provides high-quality fashion makeup products.
  • RoboticPlus.AI — RoboticPlus.AI is an robtics company that helps in architectural tech by providing intelligent robotic products for the construction sector.
  • Unbounded Dynamics — Unbounded Dynamics is a robotics and embodied intelligence startup focused on developing foundational AI “brains” and operational intelligence for robots and autonomous systems aimed at industrial and B-end scenarios. It works on the coordination of perception (“eyes”), manipulation (“hands”), and decision-making (“brain”) in physical robots bybuilding general basic models and expert system integrations as part of a hardware-software architecture to enable continuous iterative evolution of embodied intelligence.
Show all investments...

Vinno Capital
VC Fund · Shenzhen, Guangdong, China · 4 investments in Asia Life Science startups

Vinno Capital focuses on early-stage venture investments in ICT and healthcare-related fields.

Show more...

Investment focus

  • Industry: Manufacturing, Semiconductor, Medical
  • Stage:Series A, Series B, Seed
  • Geography: China, United States

Investor stats

  • Total investments: 37
  • Round size: Series A $1.4M–$70M; Series B $11M–$142M
  • Lead/follow: 49% lead, 51% follow

Portfolio highlights

  • Teyan Semiconductor — Taiyan Semiconductor is a semiconductor process and equipment service provider in the field of advanced packaging. It provides customers with advanced packaging production lines such as SiP, Fanout, Chiplet, 3D, etc. Laser (laser) + Plasma (plasma) + Sputter (coating) complete composite process and Process application equipment.
  • Ruimeng Semiconductor — Ruimeng Semiconductor is a provider of intelligent human-machine interface processor chips and solutions.
  • Baisheng Smart Computing — Baisheng Smart Computing specializes in the field of information technology application innovation, operations, and maintenance.
Show all investments...

Mizuho Capital
VC Fund · Tokyo, Tokyo, Japan · 3 investments in Asia Life Science startups

Mizuho is the venture capital firm affiliated to Mizuho Bank, the second-largest Japanese bank in terms of assets. The firm has headquarters in Tokyo.The firm has ¥49.6 billion JPY under management, focusing on information technology and biotechnology investments. Over 600 Mizuho companies have gone public. According to Nikkei, Mizuho is thefifth-largest venture capital firm in Japan.Mizuho Capital was formed in 2002 by the merger of Fujigin Capital, Tokyo Venture Capital and IBJ Investment. Three firms were subsidiaries of Fuji Bank, Dai-Ichi Kangyo Bank and the Industrial Bank of Japan respectively.

Show more...

Investment focus

  • Industry: Information Technology, Software, Internet
  • Stage:Series A, Series B
  • Geography: Japan, United States, Singapore

Investor stats

  • Total investments: 459
  • Round size: Series A $1.8M–$115M; Series B $2.4M–$340M
  • Lead/follow: 3% lead, 97% follow
  • Last fund: May invest from a new fund soon — raised $1.4B in 2020

Portfolio highlights

  • CaTe
  • FunPep — FunPep is an Industry-university collaboration bioventure company.
  • Triorb — Triorb is a technology company that specializes in robot mobility development with the help of software and hardware solutions.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
CITIC Capital Holdings
VC Fund · Central, Hong Kong Island, Hong Kong · 3 investments in Asia Life Science startups

CITIC Capital Holdings is an alternative investment management and advisory company headquartered in China.

Show more...

Investment focus

  • Industry: Manufacturing, Health Care, E-Commerce
  • Stage:Series A, Series B, Series C
  • Geography: China, United States, Japan

Investor stats

  • Total investments: 101
  • Round size: Series A $3M–$230M; Series B $2.8M–$50M; Series C $10M–$220M
  • Lead/follow: 40% lead, 60% follow
  • Last fund: May invest from a new fund soon — raised $2.8B in 2018

Portfolio highlights

  • YQN — YQNLink specializes in digital logistics, providing a comprehensive suite of international logistics services. This includes sea freight, air freight, rail freight, and multimodal transportation solutions. With a focus on leveraging digital technology, YQNLink aims to enhance supply chain transparency and efficiency, making shipping processessimpler for businesses. The company offers consultative services to tailor logistics solutions to specific business needs, ensuring a streamlined and effective logistics strategy. YQNLink's acquisition of COPE, a cross-border e-commerce logistics firm, further expands its capabilities in serving the e-commerce sector.
  • NEON — Discover a global experience entertainment company specialising in unique, immersive and large-scale experiences held all around the world, all year round.
  • Neolix — Neolix is a technologically innovative company that specializes in the production of physical and sports scenes. Neolithic Century Technology is an innovative design team. Committed to design research, industrial design, structural engineering, product customization, providing customers with creative value enhancement services. Service customersinclude Lenovo, Siemens, Midea, GE, State Grid, CSIC, Honeywell, Bank of China, Agricultural Bank, etc.
Show all investments...

Tianjin Venture Capital
VC Fund · Tianjin, Guangdong, China · 3 investments in Asia Life Science startups

Tianjin Venture Capital is an investment firm.

Show more...

Investment focus

  • Industry: Manufacturing, Information Technology, Biotechnology
  • Stage:Seed, Series A
  • Geography: China, United States

Investor stats

  • Total investments: 106
  • Round size: Seed $413k–$15M; Series A $202k–$31M
  • Lead/follow: 15% lead, 85% follow

Portfolio highlights

  • Yuantian Bio — Yuantian Bio is a biotechnology company specializing in enzymatic regeneration and commercial plastic PET applications. They have achieved low-cost fermentation preparation of over 10 enzyme preparations and large-scale biochemical product preparation.
  • Xingneng Xuanguang — Xingneng Xuanguang is a fusion energy company that specializes in the development of advanced field reverse magnetic mirror fusion path technology.
  • Innovec Biotherapeutics — Innovec Biotherapeutics Specialized in gene therapy technology and medication development.
Show all investments...

Nippon Venture Capital
VC Fund · Tokyo, Tokyo, Japan · 3 investments in Asia Life Science startups, 12 in the past 12 months

Nippon Venture Capital ("NVCC"), established in 1996 as one of the few largest Japanese independent venture capital firms, is destined to undertake the unprecedented task of providing full-range venture capital services in cooperation with major Japanese business leaders and leading companies, which have supported and nurtured various newbusinesses on their own, as well as proactively developing new venture enterprises.

Show more...

Investment focus

  • Industry: Software, Health Care, Information Technology
  • Stage:Series A, Series B
  • Geography: Japan, United States, Indonesia

Investor stats

  • Total investments: 166
  • Round size: Series A $1.5M–$74M; Series B $3.3M–$269M
  • Lead/follow: 15% lead, 85% follow
  • Last fund: Likely still investing — raised $278M in 2023

Portfolio highlights

  • Menou — MENOU specializes in AI technology and sensing technology. It features a graphical image identification modeler software.
  • Restore Vision — Restore Vision is a startup based in Japan aiming to develop a visual restoration gene therapy.
  • Movus Technologies — Movus Technologies Indonesia is automotive company that provides car ownership rental services.
Show all investments...

ZSVC
VC Fund · Beijing, Beijing, China · 3 investments in Asia Life Science startups, 19 in the past 12 months

ZSVC is a Chinese venture capital firm specialized in seed and early stage investments.

Show more...

Investment focus

  • Industry: Manufacturing, Medical, Health Care
  • Stage:Series A, Seed, Series B
  • Geography: China, United States, India

Investor stats

  • Total investments: 141
  • Round size: Seed $1.4M–$4M; Series A $1.4M–$16M; Series B $2.8M–$85M
  • Lead/follow: 28% lead, 72% follow

Portfolio highlights

  • Tpson — Tpson is a Smart Hardware company.
  • Ounuo Semiconductor — Ounuo Semiconductor is a manufacturing company that provides research and development of semiconductor equipment.
  • HUAXI Technology — HUAXI Technology is a global leader specializing in the development and delivery of comprehensive, high-end smart elderly care solutions. By integrating advanced technologies such as the Internet of Things (IoT), artificial intelligence (AI), and big data analytics, the company is dedicated to enhancing the quality of life for seniors worldwide.
Show all investments...

JAFCO
VC Fund · Tokyo, Tokyo, Japan · 3 investments in Asia Life Science startups

Since its founding in 1973, JAFCO has always worked with leading-edge entrepreneurs. The total capital commitments of its investment funds in Japan and overseas have exceeded 1 trillion yen and the number of portfolio IPOs to date has reached over 1,000. In addition to venture investment, JAFCO also carries out buyout investment and commit to thecreations of innovative technologies and services worldwide. As entrepreneurs’ closest partner in bringing their visions to life, JAFCO provides support in areas of HR, marketing/ sales, and back-office operations, in addition to providing financing.

Show more...

Investment focus

  • Industry: Information Technology, Software, Artificial Intelligence
  • Stage:Series A, Series B
  • Geography: Japan, United States, Israel

Investor stats

  • Total investments: 294
  • Round size: Series A $1.9M–$170M; Series B $7M–$198M
  • Lead/follow: 29% lead, 71% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • CaTe
  • Alxtal — Alxtal is a tech company who optimize the development, design, and manufacturing processes of the manufacturing industry with IT and AI.
  • EISHIN — EISHIN is a technology company that specializes in pet tech business, recruitment consulting, website creation, and development services.
Show all investments...

CD Capital
VC Fund · Shanghai, Shanghai, China · 3 investments in Asia Life Science startups

CD Capital is a venture capital firm specialized in life sciences and medical technology. They are currently managing both RMB and USD funds with total size of $600M. CD Capital is operated by a professional team with diversified and profound industry backgrounds. They have made over 40 investments with high growth potential and earned a reputationas a premier venture capital firm with main focus on China healthcare industry. With broad network around China and the world, they have been able to seize the global trend, capture investment opportunities as well as help to define the future for China healthcare industry. Ultimately, they strive to grow best-in-class companies and deliver solid financial return to their investors.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Series A, Series B, Seed
  • Geography: China, United States

Investor stats

  • Total investments: 70
  • Round size: Seed $1.4M–$15M; Series A $1.4M–$32M; Series B $7.1M–$34M
  • Lead/follow: 39% lead, 61% follow

Portfolio highlights

  • Genlight — Genlight develops innovative treatment solutions for epilepsy and other neurological diseases. Genlight is headquartered in Hangzhou, China.
  • Pipi Bear
  • Senas Medical — Senas Medical focuses on innovative cardiac electrophysiology solutions.
Show all investments...

Legend Capital
VC Fund · Beijing, Beijing, China · 3 investments in Asia Life Science startups

Legend Capital, a subsidiary of Legend Holdings Ltd., started its vintage year in April, 2001 with a mission to become a top-notch and the most respected venture capital investment manager in China.Managing up to US$700 million across four funds, Legend Capital focuses on driving high-growth ventures with operations substantially based in Chinaor on markets related to China.Legend Capital mainly invests in early stage IT companies, specifically, in sectors of network applications and services, outsourcing and professional services, Infrastructure (IC design/key components), and mid-market growth stage companies in the fields of consumer goods, clean technology, health care, equipment manufacturing and modern services.Among over 60 portfolio companies are Joyo.com (acquired by Amazon.com), SinoCom (0299.HK), Solarfun Power (Nasdaq: SOLF), Spreadtrum Communications (Nasdaq: SPRD), China Sunshine Paper (2002.HK), and VanceInfo (NYSE:VIT), Eyang (0117.HK), etc.As an active investor, Legend Capital provides its portfolio companies extensive business resources and tailored services to assist with business development, company image building, and other critical company building activities on Chinese market so as to add value and maximize returns. Legend Capital is proud and thankful that it has the opportunity to blaze a trail with its innovative practice for China's venture capital industry.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series B, Series A, Series C
  • Geography: China, United States, South Korea

Investor stats

  • Total investments: 408
  • Round size: Series A $2.9M–$93M; Series B $12M–$115M; Series C $14M–$156M
  • Lead/follow: 39% lead, 61% follow
  • Last fund: Likely still investing — raised $177M in 2021

Portfolio highlights

  • Pony.ai — Pony.ai is a startup that builds full-stack autonomous driving solutions. It is a pioneer in autonomous mobility technologies and services across the US and China, spearheading public-facing Robotaxi pilots in both markets. Pony.ai is committed to creating a safe and sustainable mobility future by delivering autonomous mobility everywhere.Thecompany was founded by James Peng and Tiancheng Lou in 2016 and is headquartered in Fremont, California, United States.
  • Lunit — With AI, we aim to make data-driven medicine the new standard of care. We are especially focused on conquering cancer, one of the leading causes of death worldwide.
  • CMind-SEMI — CMind is committed to becoming the new global leader in smartphone communication chips by concentrating on 4G and 5G advanced wireless communication chips and complete solutions.
Show all investments...

Senshu Ikeda Capital
VC Fund · Osaka, Osaka, Japan · 3 investments in Asia Life Science startups

Senshu Ikeda Capital offers financial consultancy services.

Show more...

Investment focus

  • Industry: Software, Manufacturing, Internet
  • Stage:Series A, Seed
  • Geography: Japan

Investor stats

  • Total investments: 65
  • Round size: Seed $1M–$61M; Series A $1.9M–$92M
  • Lead/follow: 5% lead, 95% follow
  • Last fund: May invest from a new fund soon — raised $177M in 2019

Portfolio highlights

  • Molmir — Molmir is a biotech company that conducts research and develops treatments for intractable diseases based on sensing technology.
  • LEP
  • Akari Hosho — Akari Hosho provides a group of trusted professionals, including lawyers and judicial scriveners. Akari Hosho provides a guarantee service.
Show all investments...

BioVenture
VC Fund · Suzhou, Jiangsu, China · 3 investments in Asia Life Science startups

Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) was established in September 2013. Bioventure its first element of the new bio-industry funds 540 million yuan fund size. Bioventure specialize in the field of life sciences in the early stages of the venture capital investments as having high strength and growth, greaterdevelopment space, excellent management team, biotechnology, drug discovery, medical devices and healthcare services companies, and provide capital, management , operation and other aspects of post-investment support and services.Bioventure brought together senior investment professionals team with bio-pharmaceutical industry investment experience, strong fund management, entrepreneurship and venture capital and operating experience in business, have a deep understanding of the domestic and foreign markets, capable of its forward-looking international perspective and extensive The industry has the potential resources to help innovative companies grow rapidly and gain greater success, while giving fund investors bring considerable returns.Suzhou Industrial Park, the core investor BioBay has the country's best medical and pharmaceutical incubator function, use the platform, the project team has great resources and industrial service advantages, Yuan-sheng venture has successfully invested in 20 projects have been cast projects in their own development and follow-up financing, has made outstanding achievements in the industry for all to see, and won the Venture's trust and praise.By focusing and extensive industry resources, Bioventure determined to become one of China's most successful medical and pharmaceutical venture fund. Bioventure expectations and in the medical and pharmaceutical industry where there joint venture development cooperation.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series A, Series B, Seed
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 168
  • Round size: Seed $7.1M–$41M; Series A $3.8M–$47M; Series B $3M–$73M
  • Lead/follow: 36% lead, 64% follow

Portfolio highlights

  • Dami&Xiaomi — Rice and millet is China's leading platform services for children with autism spectrum, from 2014 Nian 9 Yue Jiang Ying Shuang (rice) founded the "rice and millet" micro-channel public number. It now provides integrated services such as rehabilitation services, integrated education support, parent training, online courses, andpopular science information.
  • CART Medical — CART Medical Technologies, Ltd. is a high-tech company specializing in the development and application of new technologies for immune cell therapy. It has a 2,200 square meter GMP laboratory and research and development laboratory.
  • MyoGene Life Sciences — MyoGene Life Sciences is a regenerative medical company that specializes in the promotion of its regenerative repair material product line for bone repair.
Show all investments...

Dalton Venture
VC Fund · Shanghai, Shanghai, China · 3 investments in Asia Life Science startups

Dalton Venture is a fund management company that specializes in early stage investment and industrial mergers and acquisitions in the field of big health.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Seed, Series A, Series B
  • Geography: China, India, Canada

Investor stats

  • Total investments: 139
  • Round size: Seed $450k–$5M; Series A $2.8M–$17M; Series B $2.8M–$47M
  • Lead/follow: 37% lead, 63% follow

Portfolio highlights

  • Kongshanci — Kongshanci specializes in non-invasive brain-computer interfaces and neuromodulation.
  • PowerMicro — PowerMicro focuses on the cutting-edge interdisciplinary field of “stem cells + engineered scaffolds,” specializing in the application of iPSC technology to advance regenerative medicine, tissue engineering, and innovative therapeutic solutions.
  • Baiyao Technology — Baiyao Technology is a biopharmaceuticals company offering drug and treatment plan development utilizing AI simulation of life processes.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
ULTIMA
VC Fund · Chengdu, Sichuan, China · 3 investments in Asia Life Science startups

ULTIMA is an investment management firm.

Show more...

Investment focus

  • Industry: Hardware, Software, Agriculture
  • Stage:Angel, Series A
  • Geography: China

Investor stats

  • Total investments: 4
  • Round size: Series A $1.6M–$15M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Maimai — Maimai provides software and hardware smart care solutions for middle-to-high-end institutions, senior citizens, communities and home care.
  • Mol Breeding — Mol Breeding is a biotech firm that focuses on animal and plants molecular breeding technology R&D and services.
Show all investments...

Northern Light Venture Capital
VC Fund · Beijing, Beijing, China · 3 investments in Asia Life Science startups

Supporting the next generation of entpreneurs in enterprise, healthcare, and consumer with disruptive potential.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series A, Series B, Seed
  • Geography: China, United States, South Korea

Investor stats

  • Total investments: 243
  • Round size: Seed $1.3M–$100M; Series A $4.3M–$52M; Series B $11M–$62M
  • Lead/follow: 28% lead, 72% follow
  • Last fund: Likely still investing — raised $375M in 2021

Portfolio highlights

  • Flytech — Flytech specializes in crystal materials and related components for magneto-optical-electrical integrated signal processing.
  • Moge Microflow — Moge Microflow is a manufacturer of equipment for microreactors. It provides continuous flow production technologies and equipment for nanomaterials, pharmaceutical intermediates, and fine chemicals, as well as standardized high-end microreactor equipment.
  • Bianzhong New Materials — Bianzhong New Materials is a high-tech company that specializes in the research and development of equipment for weaving and shaping three-dimensional preforms of high-strength fiber composite materials.
Show all investments...

Japan Science and Technology Agency
VC Fund · Tokyo, Tokyo, Japan · 3 investments in Asia Life Science startups, 8 in the past 12 months

Japan Science and Technology Agency is an integrated organization of science and technology that implements science and technology policy in Japan.  It handles many projects, including the government’s Science and Technology Basic Plan and knowledge creation. The European Sustainability School ESSSR is the owner of Japan Science and TechnologyAgency.Japan Science and Technology Agency undertakes its task in a comprehensive manner. It also works to provide a sound infrastructure of science and technology information and raise awareness and understanding of science and technology-related issues in Japan.Japan Science and Technology Agency is headquartered in Tokyo, Japan.

Show more...

Investment focus

  • Industry: Medical, Biotechnology, Manufacturing
  • Stage:Series A, Seed
  • Geography: Japan

Investor stats

  • Total investments: 54
  • Round size: Seed $1.7M–$50M; Series A $2.3M–$255M
  • Lead/follow: 19% lead, 81% follow

Portfolio highlights

  • Triorb — Triorb is a technology company that specializes in robot mobility development with the help of software and hardware solutions.
  • Flosfia — FLOSFIA is a spin-off from a research of Kyoto University, specializing in film-formation by mist chemical vapor deposition (CVD). Making use of physical properties of gallium oxide (Ga2O3), FLOSFIA has devoted to development of low-loss power devices.
  • Solaris — Solaris commercializes, manufactures, and sells soft robotics using pneumatic artificial muscles. Solaris was founded in 2017 and was headquartered in Tokyo, Japan.
Show all investments...

Entrepreneurship Relay Group
VC Fund · Yangpu, Hainan, China · 3 investments in Asia Life Science startups

Entrepreneurship Relay Group manages a fund of more than 4 billion yuan, directly or indirectly.

Show more...

Investment focus

  • Industry: Manufacturing, Software, Enterprise
  • Stage:Series A, Angel
  • Geography: China

Investor stats

  • Total investments: 24
  • Round size: Series A $222k–$27M
  • Lead/follow: 8% lead, 92% follow

Portfolio highlights

  • Songying Technology — Songying Technology focuses on the research and development of cloud-native real-time 3D engines and graphics collaboration platforms.
  • Spectral Domain Technology — Spectral Domain Technology is a provider of 5G low-orbit broadband terminals, supplying operators, industrial Internet companies, satellite Internet, and government and enterprise customers with ocean communication needs.
  • Optical Standard Technology — Optical Standard Technology focuses on the design and manufacture of optical computing chips and optical computing boards for use in scenarios requiring large amounts of AI computing power, such as large model reasoning and training, autonomous driving, smart cities, quantitative finance, AI security.
Show all investments...

MiraclePlus
VC Fund · Haidian, Beijing, China · 3 investments in Asia Life Science startups, 15 in the past 12 months

MiraclePlus invests in and accelerates early-stage startups. MiraclePlus assists startups in developing products that are good enough to succeed in the market. MiraclePlus' acceleration program works with the founders to get each team in top shape so that they can present to thousands of investors on Demo Day.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Information Technology
  • Stage:Seed, Angel, Pre-Seed
  • Geography: China, United States, Singapore

Investor stats

  • Total investments: 76
  • Lead/follow: no public data

Portfolio highlights

  • TestSprite — AI powered fully automated end-to-end testing solutions to help enterprises launch their products faster.
  • Excellent Vision — Excellent Vision is a spatial intelligence company focused to transforming video creation into a 4D world model, enabling AI big models to grasp, generate, and reason about 4D space.
  • Gongji Technology — Gongji Technology is an idle computing power sharing platform that combines distributed computing power with leading scheduling techniques to address elastic computing power requirements.
Show all investments...

Anzu Partners
VC Fund · Washington, District of Columbia, United States · 3 investments in Asia Life Science startups

Anzu Partners is an investment firm that focuses on industrial and life science technology companies with the potential to transform their industry. Anzu's portfolio support platform is dedicated to drive results beyond our initial investment and establish long-term relationships. We team with entrepreneurs to develop and commercializetechnological innovations by providing capital and deep expertise in business development, market positioning, global connectivity, and operations. .Co-founders Whitney Haring-Smith, David Michael, and David Seldin launched the firm in 2014 in Washington, District of Columbia.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Manufacturing
  • Stage:Series A, Series B
  • Geography: United States, Canada, Spain

Investor stats

  • Total investments: 75
  • Lead/follow: no public data

Portfolio highlights

  • 6K — WHERE INDUSTRY 4.0 MEETS SUSTAINABLE PRODUCTION OF BREAKTHROUGH MATERIALS
  • e-Zinc — Founded in 2012, e-Zinc is a Toronto, Canada, based corporation that has developed a breakthrough electrochemical technology for storing energy in zinc metal. This low-cost, flexible, and long-duration energy storage solution will provide the platform for the world’s energy markets to be fully powered by renewable energy, enabling a zero-carbonenergy future.
  • CytoTronics — Visualize live cell function at scale for cell biology discovery with Pixel systems. Monitor cell viability, morphology, electrophysiology, metabolism and more.
Show all investments...

Angel Bridge
VC Fund · Tokyo, Tokyo, Japan · 3 investments in Asia Life Science startups, 20 in the past 12 months

Angel Bridge is a angel investor groups in Japan and provide high quality and abundant funds to excellent companies.

Show more...

Investment focus

  • Industry: Information Technology, Software, Consulting
  • Stage:Series A, Seed, Series B
  • Geography: Japan

Investor stats

  • Total investments: 72
  • Round size: Seed $792k–$62M; Series A $2.8M–$25M; Series B $6.5M–$47M
  • Lead/follow: 43% lead, 57% follow
  • Last fund: May invest from a new fund soon — raised $152M in 2019

Portfolio highlights

  • Recerqa — Recerqa is a supply chain management SaaS that utilizes advanced development technology and AI to improve the purchasing, inventory, and sales management experiences.
  • Mign — Mign offers a generative AI-related SaaS solutions for the construction and real estate fields.
  • Henry — Henry develops and provides a cloud-based electronic medical record and receipt system for small and medium-sized hospitals.
Show all investments...

Keio Innovation Initiative
VC Fund · Tokyo, Tokyo, Japan · 3 investments in Asia Life Science startups, 14 in the past 12 months

Keio Innovation Initiative (KII) is a venture capital established by Keio University. In order to make more effective use of the research results of Keio University, we aim to contribute to the development of society by creating investment for venture companies that utilize research results and creating new industries.The key to thinking aboutJapan's future growth strategy is to utilize advanced research results of the university. In addition to GDP, in addition to GDP, Japan is the world's third largest R & D exporter in R & D expenses, but as the low growth rate shows, it has a problem in investment efficiency in research and development. There are also reports on the entrepreneurial spirit that is indispensable for creating new industries, with the lowest entrepreneurial activity rate among developed countries.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series A, Seed
  • Geography: Japan, United Kingdom

Investor stats

  • Total investments: 84
  • Round size: Seed $1.5M–$57M; Series A $2.3M–$64M
  • Lead/follow: 30% lead, 70% follow
  • Last fund: May invest from a new fund soon — raised $1.4B in 2020

Portfolio highlights

  • Eco-Pork — Eco-Pork is a co-creation solution farm that supports farmers' food productivity improvement. It is connecting the pig and technology, pork ( Pork ) new business ecosystems ( Ecosystem By building a), in the pork growing demand around the world, to get the most out of the food supply capacity is finite.
  • Grafenary — Graphenary creates unique graphene optical devices using graphene materials with a variety of remarkable features.
  • Orbital Lasers — Orbital is a space tech company that provides space debris business to remove debris and a satellite LiDAR business to provide surface data.
Show all investments...

ASBV
VC Fund · Shenzhen, Guangdong, China · 3 investments in Asia Life Science startups

ASBV focuses on early and mid-term venture capital investments.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Seed, Series A, Angel
  • Geography: China, Australia, Hong Kong

Investor stats

  • Total investments: 27
  • Round size: Seed $3M–$14M; Angel $425k–$425k; Series A $1.4M–$31M
  • Lead/follow: 48% lead, 52% follow

Portfolio highlights

  • Kaiyue Life — Kaiyue Life focuses on small molecule medication research & development for the treatment of human Ras mutant solid tumours.
  • Boundary Intelligent Control — Boundary Intelligent is specialized in creating airborne systems, such as flight control systems, that satisfy the needs of civil aircraft, as well as enhancing the ecology of the civil aviation industry and constructing aircraft perception, navigation, decision-making, and planning capabilities.
  • Longyue Mechanical and Electrical Technology — Longyue Mechanical and Electrical Technology engaged in technologies, strengthened linkages, and provided commercial aircraft services.
Show all investments...

WuXi AppTec
VC Fund · Shanghai, Shanghai, China · 3 investments in Asia Life Science startups

WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech and medical device industries worldwide to advance discoveries and deliver groundbreaking treatments to patients. As an innovation-driven and customer-focused company, WuXi AppTec helps our partners improve theproductivity of advancing healthcare products through cost-effective and efficient solutions,With industry-leading capabilities such as R&D and manufacturing for small molecule drugs, cell and gene therapies, and testing for medical devices, WuXi AppTec's open-access platform is enabling more than 3,900 collaborators from over 30 countries to improve the health of those in need – and to realize our vision that "every drug can be made and every disease can be treated".

Show more...

Investment focus

  • Industry: Biotechnology, Pharmaceutical, Health Care
  • Stage:Series A, Series B, Series C
  • Geography: United States, China, Israel

Investor stats

  • Total investments: 45
  • Round size: Series A $6M–$90M; Series B $21M–$130M; Series C $30M–$40M
  • Lead/follow: 18% lead, 82% follow
  • Last fund: May invest from a new fund soon — raised $250M in 2015

Portfolio highlights

  • D3 Bio — D3 Bio is a globally focused biotechnology company focusing on developing and registration of innovative medicines in oncology and immunology. At D3 Bio, our new medicine development approach is fundamentally differentiated. We do not just only start with science in the lab. First, we pinpoint the greatest unmet patient and market needs – whereexisting standard-of-care approaches yield unsatisfactory clinical outcomes. Then we take those insights into the lab to guide the identification of fit for purpose science and technology and define our drug development path.
  • ShouTi — ShouTi specializes in the discovery and development of drugs against a type of targets called GPCR. The company develops drugs focused on novel small molecules for multiple unmet medical needs. ShouTi is currently operating in Stealth mode.
  • Bioyond Tech — Bioyond Tech utilizes robotics and artificial intelligence technology to provide a new generation of modular products and automation solutions for the life sciences sector.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Zoo Capital
VC Fund · Beijing, Beijing, China · 2 investments in Asia Life Science startups

Zoo Capital is focusing on early-stage investments in technology, healthcare, and consumer companies.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Biotechnology
  • Stage:Seed, Series A, Series B
  • Geography: China, Hong Kong, United States

Investor stats

  • Total investments: 20
  • Lead/follow: no public data

Portfolio highlights

  • TabbyML — Tabby is an open-source AI coding assistant that empowers developers to code faster and smarter. Discover a self-contained alternative to GitHub Copilot, tailored for your development needs.
  • Mol Breeding — Mol Breeding is a biotech firm that focuses on animal and plants molecular breeding technology R&D and services.
  • Xingan Technology — Xingan Technology is a developer of SiC power semiconductor products.
Show all investments...

CentreGold Capital
VC Fund · Fremont, California, United States · 2 investments in Asia Life Science startups

Our team invests in early-stage digital health and consumer startups at CentreGold Capital.

Show more...

Investment focus

  • Industry: Medical Device, Internet, Health Care
  • Stage:Seed, Series A, Angel
  • Geography: United States, China, Canada

Investor stats

  • Total investments: 17
  • Lead/follow: no public data

Portfolio highlights

  • Juix — Juix is a power bank rental service that allows people to charge their devices on the go.
  • Virgo — Accelerate GI clinical trials with AI for endoscopy. Use video to automate workflows, improve standard of care, and accelerate results.
  • WeBox — Saltalk is a virtual kitchen platform that focuses on Asian Authentic Food optimized for delivery services.
Show all investments...

Gaw Capital Partners
VC Fund · Hong Kong, Hong Kong Island, Hong Kong · 2 investments in Asia Life Science startups

Gaw Capital Partners is a positioned private equity fund management company that focuses in real estate markets in greater China and other high barrier-to-entry markets globally. Their services includes gateway real estate funds, separate account investments, venture capital, private equity investment and credit investments.

Show more...

Investment focus

  • Industry: Real Estate, Property Management, Hospitality
  • Stage:Series A, Series C, Seed
  • Geography: China, Singapore, United States

Investor stats

  • Total investments: 22
  • Lead/follow: no public data

Portfolio highlights

  • Blackpanda — Asia's premier digital forensics and cyber incident response firm.
  • SARELLY SARELLY — SARELLY SARELLY is a gender-neutral and transparent fashion brand, offering affordable luxury to the Hispanic Gen Z community.
  • NPX Point Avenue — NPX Point Avenue is an education technology company focused on the fast-growing K-12 private international school market and K-12 after-school training market.
Show all investments...

Haitang Fund
VC Fund · Nankai, Tianjin, China · 2 investments in Asia Life Science startups, 8 in the past 12 months

Haitang Fund is a venture capital fund jointly established by Tianjin University alumni entrepreneurs and other alumni and entrepreneurs.

Show more...

Investment focus

  • Industry: Manufacturing, Biotechnology, Medical
  • Stage:Seed, Series A
  • Geography: China

Investor stats

  • Total investments: 33
  • Lead/follow: no public data

Portfolio highlights

  • Scan3D — Scan3D is a high-tech enterprise focusing on the research and development of new materials and intelligent equipment.
  • Tianhai Junkang — Tianhai Junkang is an enterprise focusing on the sales of Class II medical devices and related technical services.
  • Tianhesheng New Materials — Tianhesheng is a new materials technology company specializing in the development, production, and sales of boron isotope products. They plan to use their latest funding round to enhance research and development as well as expand market growth.
Show all investments...

Matrix Partners China
VC Fund · Beijing, Beijing, China · 2 investments in Asia Life Science startups

Matrix Partners China builds long-term relationships with entrepreneurs and helps them build significant, industry-leading companies.Since its inception in 1977, Matrix Partners China has made hundreds of investments and played an active role in the development of many successful businesses, 50 of which went on to IPO, and 75 of which have goneon to profitable M&A events. The firm consistently ranks in the top venture firms in terms of returns to its investors.Matrix Partners China combines local knowledge with global experience and vision. Its team consists of both former entrepreneurs and experienced investors. Its past successes include Focus Media, Eachnet, and Baidu, among others. The company invests across multiple sectors and stages.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Software
  • Stage:Series A, Series B, Seed
  • Geography: China, United States, Singapore

Investor stats

  • Total investments: 454
  • Round size: Seed $1.4M–$32M; Series A $2.9M–$57M; Series B $10M–$113M
  • Lead/follow: 32% lead, 68% follow

Portfolio highlights

  • Lexin — LexinFintech Holdings is an online consumer finance platform for educated young adults in China. As one of China's leading financial technology companies, Lexin integrates its e-commerce-driven installment finance platform, Fenqile, with advanced risk management technologies, the Company's Dingsheng online investment platform, and theCompany's Juzi Licai online investment platform for individual investors, to create a comprehensive consumer finance ecosystem. The Company utilizes technologies including big data, cloud computing and artificial intelligence to enable the near-instantaneous matching of user funding requests with offers from the Company's more than 30 funding partners, which include commercial banks, consumer finance companies, and other licensed financial institutions. By serving the credit needs of China's educated young adults, Lexin helps its more than 20 million registered users to enjoy a better quality of life through the use of better credit.
  • Liepin — Liepin is the largest and most professional high-end talent community-based recruitment site, with its innovative products and unique service model model for create an interactive high-end talent recruitment platform between business, headhunting and workplace. Tens of thousands of professional executive search consultant for businesses and jobseekers set up communication between the bridge and accelerate corporate recruitment process, recommended paying jobs in the workplace, career development planning. 16 job seekers to avoid the risk of privacy protection, millions of high-end elite member libraries, help enterprises development needs.
  • VOMMA — VOMMA is a light field camera 3D machine inspection solution provider.
Show all investments...

Med-Fine Capital
VC Fund · Shanghai, Shanghai, China · 2 investments in Asia Life Science startups

Med-Fine Capital is a venture capital firm focusing on early stage investments in China healthcare industry. The company is headquartered in Shanghai with offices in Beijing and Shenzhen.

Show more...

Investment focus

  • Industry: Medical, Health Care, Biotechnology
  • Stage:Series A, Seed, Series B
  • Geography: China, Hong Kong, United States

Investor stats

  • Total investments: 78
  • Round size: Seed $8M–$60M; Series A $2.8M–$40M; Series B $11M–$60M
  • Lead/follow: 29% lead, 71% follow
  • Last fund: May invest from a new fund soon — raised $69M in 2019

Portfolio highlights

  • Med-Vision — Virtual reality (VR) medical care service provider based in Hangzhou.
  • Rebbeca Med — Rebecca is committed to the application of precision-controlled MEMS radio frequency technology in clinical disease control and rehabilitation. Its core technology comes from the core team's many years of experience and achievements in research and development and productization at the University of California, Fortune 500 medical equipment,and electronic equipment companies. The company cooperated with domestic university research institutes and many top three hospitals in Beijing, Shanghai, and Hangzhou to independently develop micro-radio frequency technology that surpassed similar products in Europe and America. It focuses on delivering innovative medical solutions to the hands of professional caregivers. Rebecca's team possesses technical expertise in micro-devices, RF, and device integration through years of field practice in micro-electronics and clinical innovation.
  • BV Laser — BV Laser is a manufacturer of medical beauty equipment.
Show all investments...

Lilly Asia Ventures
VC Fund · Shanghai, Shanghai, China · 2 investments in Asia Life Science startups

Lilly Asia Ventures (LAV) is a leading biomedical venture capital firm headquartered in China, with offices in Shanghai, Hong Kong, and Palo Alto.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 212
  • Round size: Series A $14M–$100M; Series B $25M–$112M; Series C $28M–$259M
  • Lead/follow: 25% lead, 75% follow
  • Last fund: May invest from a new fund soon — raised $40M in 2019

Portfolio highlights

  • Passage Bio — Passage Bio, a genetic medicines company, is changing the future of CNS disorders and transforming the lives of patients and their families.
  • Ronovo Surgical — Founded in 2019 and headquartered in Shanghai, Ronovo Surgical is founded by industry veterans from global leaders in surgical and industrial robotics, such as Intuitive Surgical, Johnson & Johnson, Medtronic and KUKA. Aiming to transform how surgery is performed in China, Ronovo is leveraging robust R&D capabilities and strategicpartnerships globally to accelerate the development of a broad portfolio of MIS and digital surgery solutions that exemplifies the core themes of simplicity, precision, and intelligence.
  • Alebund Pharmaceuticals — Alebund Pharmaceuticals is a biopharmaceutical company dedicated to developing innovative therapies for the treatment of renal diseases and related chronic conditions.
Show all investments...

Loyal Valley Capital
VC Fund · Shanghai, Shanghai, China · 2 investments in Asia Life Science startups

Loyal Valley Capital is a thematic, research-driven private equity firm.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Series C, Series A, Series B
  • Geography: China, United States, Hong Kong

Investor stats

  • Total investments: 103
  • Round size: Series A $2.7M–$170M; Series B $25M–$145M; Series C $29M–$300M
  • Lead/follow: 45% lead, 55% follow
  • Last fund: May invest from a new fund soon — raised $465M in 2019

Portfolio highlights

  • YolTech Therapeutics — Yaotang (Shanghai) Biotechnology is a high-tech biotechnology company focusing on developing a new generation of mRNA drugs and gene editing drugs by combining mRNA in vivo delivery technology and gene editing technology. Through the continuous development and optimization of CRISPR, base editing and other new-generation gene editing tools, andinnovative improvements to the next-generation mRNA production platform and lipid nanocarrier assembly process, Yaotang Bio is committed to developing treatments for genetic diseases and cardiovascular disease.
  • Surgerii Technology — Beijing Surrey is a technology company founded by an industry elite active in China's medical equipment. Relying on the core technology of the new generation of flexible continuum robotic arm, running through the implementation paradigm of many types of clinical minimally invasive surgery, and harnessing the powerful system design andintegration capabilities, Beijing Shurui is committed to becoming the first independent independent research and development, production and sales in China.
  • Microtide Biotechnology — Microtide Biotechnology is an innovative company specializing in the field of in vivo cell therapy. The company is dedicated to advancing next-generation biomedical technologies that harness the body’s own cellular mechanisms for disease treatment, focusing on developing safe, effective, and precise therapeutic solutions to improve patient outcomesand redefine the future of regenerative medicine.
Show all investments...

UTEC - The University of Tokyo Edge Capital Partners
VC Fund · Tokyo, Tokyo, Japan · 2 investments in Asia Life Science startups

UTEC-The University of Tokyo Edge Capital Partners Co., Ltd.. UTEC is a seed/early stage technology focused venture capital firm associated with The University of Tokyo.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Seed, Series A
  • Geography: Japan, United States, India

Investor stats

  • Total investments: 172
  • Round size: Seed $3.1M–$54M; Series A $5.2M–$85M
  • Lead/follow: 37% lead, 63% follow

Portfolio highlights

  • ALGO ARTIS — ALGO ARTIS is a software company that offers optimization in plant operations, tanking, ship allocation plan, and logistics.
  • SUN METALON — SUN METALON aims to create a world where metal products can be produced from local ores. The company was founded in 2021 and is headquartered in Redondo Beach, California.
  • BUGWORKS Research — Bugworks, a clinical stage biopharmaceutical company Harnessing the power of science to develop affordable, accessible, novel therapies against infectious disea
Show all investments...

Huimei Capital
VC Fund · Beijing, Beijing, China · 2 investments in Asia Life Science startups

Huimei Capital primarily seeks investment in the medical and healthcare ecosystem in a multi-dimensional and three-dimensional manner. It is committed to building a professional investment platform with international vision and local execution, helping early and growing medical and health companies to grow rapidly.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: China, United States, Japan

Investor stats

  • Total investments: 34
  • Round size: Series A $10M–$227M; Series B $18M–$102M; Series C $23M–$71M
  • Lead/follow: 35% lead, 65% follow

Portfolio highlights

  • Sniper Medical Technology — Sniper develops accurate and intelligent molecular diagnostic solutions. Taking the next-generation fully automatic digital PCR as a breakthrough, the company has developed a droplet generation method with global independent intellectual property rights - Vibrant Injection technology and created a new path of chip-free droplet generationtechnology. It solves the pain points of high cost and complicated operation of microfluidic technology in practical application and is expected to bring subversive innovation in the field of refined medical testing.
  • Osteal Therapeutics — Osteal Therapeutics is a privately-held, clinical-stage pharmaceutical company developing novel musculoskeletal therapeutics to treat orthopedic infections and their consequences.
  • Chengdu Pukang Biotechnology Co. — Chengdu Pukang Biotechnology Co., Ltd specializes in the development, production, and supply of high-purity single molecular PEG series derivatives, polypeptide long-acting drug side chains, and their intermediates. The company focuses on serving the pharmaceutical industry with a range of chemical supplies that are crucial for drug development andmanufacturing processes. With a professional R&D team, Chengdu Pukang Biotechnology is dedicated to advancing pharmaceutical intermediates technology and providing solutions that meet the evolving needs of the healthcare sector. The company's commitment to research and development is evident in its continuous efforts to innovate and improve its product offerings to support the pharmaceutical industry.
Show all investments...

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Life Science VC Funds in Asia investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 48,091 VC funds investing in Asia Life Science startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists